Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model

Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE

(2011) Christina Monetti et al.   ELECTROPHORESIS

GEMMA and MALDI-TOF MS of reactive PEGs for pharmaceutical applications

(2010) Jasmin Kemptner et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A

(2010) B Baumgartner et al.   LABORATORY ANIMALS

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

(2009) M. Qadura et al.   BLOOD

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

(2009) P. W. COLLINS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Mechanisms maintaining peripheral tolerance

(2009) Daniel L Mueller   NATURE IMMUNOLOGY

Checkpoints in lymphocyte development and autoimmune disease

(2009) Harald von Boehmer et al.   NATURE IMMUNOLOGY

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

(2009) Kajsa Wing et al.   NATURE IMMUNOLOGY